Development of Allosteric Polo-like Kinase Inhibitor

Working with the Medical Research Council Cancer Unit, we have recently published a study charting the development of an inhibitor for the PLK1 polo-box domain. The paper titled “Modulating Protein-Protein Interactions of the Mitotic Polo-like Kinases to Target Mutant KRAS” is published in Cell Chemical Biology

© 2020 Theory of Condensed Matter Group, Cavendish Laboratory, JJ Thomson Avenue, Cambridge, CB3 0HE, United Kingdom